Assessment of genotoxic potential of serially diluted whole tobacco smoke using ames micronucleus and PIG-a assays.
Ended Awarded Last action
- Contract number
- HHSF22301005T
- Awardee
-
Lovelace Biomedical And Environmental Research Institute, Inc. UEI N1UBCLRAPNG6
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,412,105
Award facts
- Opportunity
-
- 900000000 Solicitation number
- Contract value 100% obligated
- $1,412,105.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- PSC
- AJ11 General Science And Technology R&D Services; General Science And Technology; Basic Research
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Albuquerque, NM 87108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Change Order | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,412,105 |
About this award
This firm-fixed-price delivery order was issued under the Department of Health and Human Services (HHS) Food and Drug Administration (FDA) "In Vivo Toxicology of Tobacco 2015-2020" indefinite-delivery, indefinite-quantity (IDIQ) contract. The $1,412,105.00 contract was awarded to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), doing business as Inhalation Toxicology Research Institute, a non-profit contract research organization. The contract is for the "Assessment of Genotoxic Potential of Serially Diluted Whole Tobacco Smoke Using Ames Micronucleus and PIG-A Assays". There was no set-aside designation for this award. LBERI has expertise in areas such as inhalation toxicology, infectious disease modeling, and translational science, and conducts research on behalf of federal agencies including NIH, NIAID, NCATS, and BARDA.
Quick answers
Who was awarded contract HHSF22301005T?
HHSF22301005T was awarded to Lovelace Biomedical And Environmental Research Institute, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 8, 2017.
How much is contract HHSF22301005T worth?
The government has obligated $1,412,105 on HHSF22301005T.
Is contract HHSF22301005T an order under another contract?
Yes. HHSF22301005T is a delivery order under HHSF223201510001I, an indefinite delivery contract, on In Vivo Toxicology of Tobacco 2015-2020.
Was contract HHSF22301005T competed?
The extent of competition for HHSF22301005T was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award